These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 35777361)

  • 1. What SARS-CoV-2 does to our brains.
    Aschman T; Mothes R; Heppner FL; Radbruch H
    Immunity; 2022 Jul; 55(7):1159-1172. PubMed ID: 35777361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encephalitic syndrome and anosmia in COVID-19: Do these clinical presentations really reflect SARS-CoV-2 neurotropism? A theory based on the review of 25 COVID-19 cases.
    Pouga L
    J Med Virol; 2021 Jan; 93(1):550-558. PubMed ID: 32672843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?
    Murta V; Villarreal A; Ramos AJ
    ASN Neuro; 2020; 12():1759091420954960. PubMed ID: 32878468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neurobiology of SARS-CoV-2 infection.
    Meinhardt J; Streit S; Dittmayer C; Manitius RV; Radbruch H; Heppner FL
    Nat Rev Neurosci; 2024 Jan; 25(1):30-42. PubMed ID: 38049610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 and the nervous system: current perspectives.
    Pattanaik A; Bhandarkar B S; Lodha L; Marate S
    Arch Virol; 2023 Jun; 168(6):171. PubMed ID: 37261613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-Cov-2 infection and neuropathological findings: a report of 18 cases and review of the literature.
    Lebrun L; Absil L; Remmelink M; De Mendonça R; D'Haene N; Gaspard N; Rusu S; Racu ML; Collin A; Allard J; Zindy E; Schiavo AA; De Clercq S; De Witte O; Decaestecker C; Lopes MB; Salmon I
    Acta Neuropathol Commun; 2023 May; 11(1):78. PubMed ID: 37165453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential mechanism of SARS-CoV-2-associated central and peripheral nervous system impairment.
    Zhang Y; Chen X; Jia L; Zhang Y
    Acta Neurol Scand; 2022 Sep; 146(3):225-236. PubMed ID: 35699161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models.
    Bauer L; Lendemeijer B; Leijten L; Embregts CWE; Rockx B; Kushner SA; de Vrij FMS; van Riel D
    mSphere; 2021 Jun; 6(3):e0027021. PubMed ID: 34160239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should we expect neurological symptoms in the SARS-CoV-2 epidemic?
    Matías-Guiu J; Gomez-Pinedo U; Montero-Escribano P; Gomez-Iglesias P; Porta-Etessam J; Matias-Guiu JA
    Neurologia (Engl Ed); 2020 Apr; 35(3):170-175. PubMed ID: 32299636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuro-COVID-19: an insidious virus in action.
    Bratosiewicz-Wąsik J
    Neurol Neurochir Pol; 2022; 56(1):48-60. PubMed ID: 34642927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological, cellular, and molecular basis of brain infection in COVID-19 patients.
    Crunfli F; Carregari VC; Veras FP; Silva LS; Nogueira MH; Antunes ASLM; Vendramini PH; Valença AGF; Brandão-Teles C; Zuccoli GDS; Reis-de-Oliveira G; Silva-Costa LC; Saia-Cereda VM; Smith BJ; Codo AC; de Souza GF; Muraro SP; Parise PL; Toledo-Teixeira DA; Santos de Castro ÍM; Melo BM; Almeida GM; Firmino EMS; Paiva IM; Silva BMS; Guimarães RM; Mendes ND; Ludwig RL; Ruiz GP; Knittel TL; Davanzo GG; Gerhardt JA; Rodrigues PB; Forato J; Amorim MR; Brunetti NS; Martini MC; Benatti MN; Batah SS; Siyuan L; João RB; Aventurato ÍK; Rabelo de Brito M; Mendes MJ; da Costa BA; Alvim MKM; da Silva Júnior JR; Damião LL; de Sousa IMP; da Rocha ED; Gonçalves SM; Lopes da Silva LH; Bettini V; Campos BM; Ludwig G; Tavares LA; Pontelli MC; Viana RMM; Martins RB; Vieira AS; Alves-Filho JC; Arruda E; Podolsky-Gondim GG; Santos MV; Neder L; Damasio A; Rehen S; Vinolo MAR; Munhoz CD; Louzada-Junior P; Oliveira RD; Cunha FQ; Nakaya HI; Mauad T; Duarte-Neto AN; Ferraz da Silva LF; Dolhnikoff M; Saldiva PHN; Farias AS; Cendes F; Moraes-Vieira PMM; Fabro AT; Sebollela A; Proença-Modena JL; Yasuda CL; Mori MA; Cunha TM; Martins-de-Souza D
    Proc Natl Acad Sci U S A; 2022 Aug; 119(35):e2200960119. PubMed ID: 35951647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS.
    Szabo MP; Iba M; Nath A; Masliah E; Kim C
    Exp Mol Med; 2022 Apr; 54(4):447-454. PubMed ID: 35396576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotropism and Neuropsychiatric Symptomsi in Patients with COVID-19.
    Moretti P; Brufani F; Pierotti V; Pomili G; Di Buò A; Giulietti C; Masini F; Tanku V; Bachetti MC; Menculini G; Tortorella A
    Psychiatr Danub; 2021 Dec; 33(Suppl 11):10-13. PubMed ID: 34862882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computing the Effects of SARS-CoV-2 on Respiration Regulatory Mechanisms in COVID-19.
    Baig AM
    ACS Chem Neurosci; 2020 Aug; 11(16):2416-2421. PubMed ID: 32600045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does SARS-Cov-2 invade the brain? Translational lessons from animal models.
    Natoli S; Oliveira V; Calabresi P; Maia LF; Pisani A
    Eur J Neurol; 2020 Sep; 27(9):1764-1773. PubMed ID: 32333487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?
    Burks SM; Rosas-Hernandez H; Alejandro Ramirez-Lee M; Cuevas E; Talpos JC
    Brain Behav Immun; 2021 Jul; 95():7-14. PubMed ID: 33412255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral microvascular complications associated with SARS-CoV-2 infection: How did it occur and how should it be treated?
    Omidian N; Mohammadi P; Sadeghalvad M; Mohammadi-Motlagh HR
    Biomed Pharmacother; 2022 Oct; 154():113534. PubMed ID: 35994816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2-specific neuropathology: fact or fiction?
    Pröbstel AK; Schirmer L
    Trends Neurosci; 2021 Dec; 44(12):933-935. PubMed ID: 34716032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging neurotropic features of SARS-CoV-2.
    Zhan WR; Huang J; Zeng PM; Tian WY; Luo ZG
    J Mol Cell Biol; 2021 Dec; 13(10):705-711. PubMed ID: 34289037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.